These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 3276052

  • 1. Treatment of chronic renal allograft rejection with cyclosporine and prednisone.
    Rosenblum ND, Harmon WE, Levey RH.
    Transplantation; 1988 Jan; 45(1):232-4. PubMed ID: 3276052
    [No Abstract] [Full Text] [Related]

  • 2. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES, Heffron TG, Stuart JK, Thistlethwaite JR, Stuart FP.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract] [Full Text] [Related]

  • 3. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP, Mendez-Picon G, King A, Nelson KP, Spicer HG, Lee HM.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract] [Full Text] [Related]

  • 4. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC, Johnson K, Richie R, Nylander W, McMahon Y, Niblack G, Green W, Morrissey J, Ynares C.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract] [Full Text] [Related]

  • 5. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA, Aquino A, Ali A, Rodriguez R, Ali S.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract] [Full Text] [Related]

  • 6. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
    Feduska NJ, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Salvatierra O.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
    Canafax DM, Simmons RL, Sutherland DE, Fryd DS, Strand MH, Ascher NL, Payne WD, Najarian JS.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
    [No Abstract] [Full Text] [Related]

  • 17. Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation.
    Henry ML, Sommer BG, Ferguson RM.
    Am J Surg; 1985 Nov; 150(5):533-6. PubMed ID: 2998215
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation.
    Sutherland DE, Strand M, Fryd DS, Ferguson RM, Simmons RL, Ascher NL, Najarian JS.
    Am J Kidney Dis; 1984 May; 3(6):456-61. PubMed ID: 6372449
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.